1. Home
  2. TOST vs ILMN Comparison

TOST vs ILMN Comparison

Compare TOST & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toast Inc.

TOST

Toast Inc.

HOLD

Current Price

$29.28

Market Cap

18.3B

Sector

Technology

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$134.99

Market Cap

19.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOST
ILMN
Founded
2012
1998
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3B
19.4B
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
TOST
ILMN
Price
$29.28
$134.99
Analyst Decision
Buy
Hold
Analyst Count
22
17
Target Price
$41.29
$124.24
AVG Volume (30 Days)
8.0M
1.3M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
1766.67
170.87
EPS
0.56
5.45
Revenue
$6,153,000,000.00
$4,343,000,000.00
Revenue This Year
$22.69
$6.47
Revenue Next Year
$18.03
$5.58
P/E Ratio
$51.17
$23.49
Revenue Growth
24.05
N/A
52 Week Low
$24.35
$73.86
52 Week High
$49.66
$155.53

Technical Indicators

Market Signals
Indicator
TOST
ILMN
Relative Strength Index (RSI) 58.32 58.53
Support Level $24.80 $127.99
Resistance Level $29.66 $137.09
Average True Range (ATR) 0.97 5.00
MACD 0.12 -0.09
Stochastic Oscillator 86.93 83.67

Price Performance

Historical Comparison
TOST
ILMN

About TOST Toast Inc.

Toast is an end-to-end technology platform designed to address the complex needs of the restaurant industry. The company generates point-in-time revenue through sales of its restaurant-grade hardware and recurring revenue in the form of take rates on restaurant transaction volume as well as subscriptions to its software solutions. As of fiscal 2024, the company provided services to 134,000 restaurant locations primarily in the US. Toast's typical customer is a mid-market restaurant generating slightly more than $1 million in revenue annually.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: